Discover the groundbreaking treatment option, SPRAVATO®, the first prescription nasal spray, combined with an oral antidepressant. This innovative therapy is designed for adults facing treatment-resistant depression, a condition diagnosed when individuals, despite trying at least two different antidepressants of adequate dose and duration, continue to struggle with major depressive disorder.

In SPRAVATO® clinical trials, our therapy has shown promise in alleviating depressive symptoms in adults with major depressive disorder, including those with suicidal thoughts or actions. It is important to note that SPRAVATO® is not intended for use as an anesthetic or to prevent or relieve pain. Safety and effectiveness for use in preventing suicide or reducing suicidal thoughts or actions are not confirmed.

Consult your healthcare provider for personalized guidance. SPRAVATO® is not a replacement for hospitalization if deemed necessary, even if improvement is experienced after the initial dose. Please note that the safety and effectiveness of SPRAVATO® in children are not established. Experience a new frontier in mental health treatment with SPRAVATO® at IM-Wellness in San Antonio, Texas


At Insight Mental Wellness (IMW) in San Antonio, Texas, our dedicated providers and staff are your companions on a personalized wellness journey. Grounded in science and proven practices, our programs are optimized to help you overcome obstacles and reach your full potential.

As your positive and supportive ally, we offer a compassionate team trained in psychedelic support, covering preparation, navigation, and integration. Our focus is on Ketamine, an FDA-approved medication since 1970, acting as an NMDA receptor antagonist and enhancing neuroplasticity by increasing Brain-Derived Neurotrophic Factor (BDNF) expression. From young children to seniors, Ketamine is well-tolerated and has a rich history of efficacy.

Experience the pleasant and often rapid benefits of Esketamine, a form of intranasal administered Ketamine treatment. Backed by substantial clinical research, Esketamine has demonstrated safety and efficacy in treating mental health disorders, with studies revealing higher response rates and fewer lasting side effects. Let IMW guide you through this transformative journey to mental wellness.

It is FDA approved for Treatment for the following diagnosis:

  • Major depression,
  • Treatment-Resistant depression
  • Post-traumatic stress disorder,
  • Suicidal Ideation
  • Anxiety disorder.
  • Some off-label uses include treatment for OCD, and other mental health-related conditions.
  • Your treatment plan will include psychotherapy sessions to help optimize your experience and achieve lasting change.

Ketamine has a safety record, but as with any medication, it is not without risks. Consult your clinician about the risks and any potential complications that may exclude you as a candidate before determining if it’s the right fit for you. Additionally, make sure to follow your medical team’s treatment plan and contact the clinic to let them know immediately if you experience any adverse reactions.

Some side effects of Esketamine treatment may include altered sense of time, anxiety, blurred vision, diminished ability to see/hear/feel, dry mouth, elevated blood pressure or heart rate, elevated intraocular or intracranial pressure, excitability, loss of appetite, mental confusion, nausea/vomiting, nystagmus (rapid eye movements), restlessness, slurred speech, synesthesia (a mingling of the senses).

Do not proceed with Esketamine treatment if any of the following apply to you:

  • Allergic to ketamine and ketamine related products.
  • Symptoms of psychosis or mania.
  • Uncontrolled high blood pressure CHF or other serious heart problem.
  • Severe breathing problem
    History of elevated intraocular or intracranial pressure.
  • History of hyperthyroidism
    Other serious medical illness
    Under the age of 18 years old.
    Pregnant, nursing, or trying to become pregnant.

Esketamine has been reported to produce issues including, but not limited to, those listed below. However, lasting adverse side-effects are rare when medical protocols are carefully followed.

Esketamine has been shown to cause moderate psychological dependency in some recreational users.

In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
Esketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders.
Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including Esketamine, and discuss potential risks with your IMW clinician before proceeding with treatment.
The dissociative effects of Esketamine may increase patient vulnerability and the risk of accidents.
To promote positive outcomes and ensure safety, follow these Esketamine treatment guidelines:

Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep (24 hours after treatment)
Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
Continue to take antihypertensive medication as prescribed
Avoid hangovers or alcohol intake
Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
Esketamine treatment should never be conducted without a monitor present to ensure your safety
Ensure you have a safe form of transportation to and from the treatment session.